Edition:
India

Akorn Inc (AKRX.OQ)

AKRX.OQ on NASDAQ Stock Exchange Global Select Market

32.37USD
22 Nov 2017
Change (% chg)

-- (--)
Prev Close
$32.37
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
565,457
52-wk High
$33.99
52-wk Low
$17.61

Select another date:

Wed, Nov 22 2017

Fresenius says Akorn deal closure could take until next year

FRANKFURT, Nov 22 German healthcare group Fresenius SE said the planned takeover of Akorn , a U.S. maker of liquid generic drugs, might not be completed before next year as the U.S. antitrust review could take longer than expected.

UPDATE 1-Fresenius says Akorn troubles could continue into next year

FRANKFURT, Nov 2 German healthcare group Fresenius SE said on Thursday that weakness at Akorn , the U.S. maker of liquid generic drugs it has agreed to buy, could continue into next year but the deal was still worth it over the longer term.

Insys founder Kapoor steps down as Akorn chairman after arrest

NEW YORK John Kapoor, the billionaire founder of opioid maker Insys Therapeutics Inc , has resigned as chairman of drugmaker Akorn Inc , just days after his arrest on charges he participated in a scheme to bribe doctors to prescribe a potent pain medication while he was at Insys.

Insys founder Kapoor steps down as Akorn chairman after arrest

NEW YORK John Kapoor, the billionaire founder of opioid maker Insys Therapeutics Inc, has resigned as chairman of drugmaker Akorn Inc, just days after his arrest on charges he participated in a scheme to bribe doctors to prescribe a potent pain medication while he was at Insys.

Senvest Management shorting drug stocks Insys, Akorn, Fresenius

TEL AVIV, Oct 3 New York-based Senvest Management is shorting three drug stocks, Insys Therapeutics Inc , Akorn Inc and Fresenius SE, its chief executive Richard Mashaal said on Tuesday,

BRIEF-Fresenius SE says Akorn shareholders approved merger

* At yesterday's special meeting, shareholders of Akorn, Inc., have approved merger agreement with fresenius kabi, with 83.9 percent of outstanding shares being voted in favour of transaction. Source text for Eikon: Further company coverage:

BRIEF-Akorn shareholders vote to approve merger agreement with Fresenius Kabi

* Akorn shareholders vote to approve merger agreement with Fresenius Kabi

Select another date: